Ultragenyx Pharmaceutical, Inc. (RARE)
26.46
-0.38
(-1.42%)
USD |
NASDAQ |
May 13, 16:00
26.50
+0.04
(+0.15%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Free Cash Flow : -507.20M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Catalyst Pharmaceuticals, Inc. | 208.13M |
| Regeneron Pharmaceuticals, Inc. | 3.791B |
| BioMarin Pharmaceutical, Inc. | 759.12M |
| Xencor, Inc. | -188.84M |
| REGENXBIO, Inc. | -126.38M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -197.00M |
| Cash from Investing (Quarterly) | -49.00M |
| Free Cash Flow Per Share (Quarterly) | -2.018 |
| Free Cash Flow to Equity (Quarterly) | -151.00M |
| Free Cash Flow to Firm (Quarterly) | -181.89M |
| Free Cash Flow Yield | -19.23% |